{"reporting_entity_name": "John Hopkins Health Plans","reporting_entity_type": "Commercial","last_updated_on": "2026-08-26","version": "2.0","provider_references": [                                                                                                                                                                   
{"provider_group_id":635825491,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1003910878,1073720827,1114021086,1124122999,1144632936,1164892154,1336243104,1396994489,1417337999,1457455222,1497859268,1558465328,1558466334,1598703928,1629172499,1639315864,1649374414,1649487497,1740222504,1750485520],"tin":{"type":"ein","value":"042553140","business_name":"FRESENIUS MEDICAL CARE FRANKLIN SQUARE HOME"}}]},
{"provider_group_id":635825492,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1013344811],"tin":{"type":"ein","value":"463691012","business_name":"FRESENIUS MEDICAL CARE SURRATS"}}]},
{"provider_group_id":635825493,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1013455211],"tin":{"type":"ein","value":"824003478","business_name":"FRESENIUS KIDNEY CARE GERMANTOWN"}}]},
{"provider_group_id":635825494,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1023648284],"tin":{"type":"ein","value":"844274933","business_name":"FRESENIUS MEDICAL CARE BOWIE LLC"}}]},
{"provider_group_id":635825495,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1053772079,1134580152,1235590241,1306207329,1679934699,1689035693],"tin":{"type":"ein","value":"810827823","business_name":"FRESENIUS KIDNEY CARE"}}]},
{"provider_group_id":635825496,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1144783598,1588142814,1861955213],"tin":{"type":"ein","value":"831318324","business_name":"FRESENIUS MEDICAL CARE SOUTHERN MARYLAND HOME LLC"}}]},
{"provider_group_id":635825497,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1164604864],"tin":{"type":"ein","value":"203275966","business_name":"RAI-BALTIMOER-BELTSVILLE"}}]},
{"provider_group_id":635825498,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1174997225],"tin":{"type":"ein","value":"474851198","business_name":"FRESENIUS MEDICAL CARE TOWSON"}}]},
{"provider_group_id":635825499,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1225615479],"tin":{"type":"ein","value":"842317502","business_name":"FRESENIUS KIDNEY CARE WALDORF W"}}]},
{"provider_group_id":635825500,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1275763492,1487945069],"tin":{"type":"ein","value":"263611853","business_name":"FRESENIUS MEDICAL CARE KAMI PARTNERS LLC"}}]},
{"provider_group_id":635825501,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1295077329,1821330952],"tin":{"type":"ein","value":"462234348","business_name":"FRESENIUS MEDICAL CARE ESSEX DUNDALK LLC"}}]},
{"provider_group_id":635825502,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1407381155],"tin":{"type":"ein","value":"813061229","business_name":"FRESENIUS KIDNEY CARE OF FREDERICK"}}]},
{"provider_group_id":635825503,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1457707291,1699121517],"tin":{"type":"ein","value":"474399250","business_name":"FRESENIUS MEDICAL CARE NW BALTIMORE"}}]},
{"provider_group_id":635825504,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1538615463],"tin":{"type":"ein","value":"811608302","business_name":"FRESENIUS MEDICAL CARE ELKTON"}}]},
{"provider_group_id":635825505,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1558605501,1952405722],"tin":{"type":"ein","value":"010680750","business_name":"FRESENIUS ANNE ARUNDEL OUTPATIENT DIALYSIS SVC"}}]},
{"provider_group_id":635825506,"network_name":["EHP Non PCP Network"],"provider_groups":[{"npi":[1710547344],"tin":{"type":"ein","value":"830705199","business_name":"FRESENIUS KIDNEY CARE FAIRMOUNT HEIGHTS"}}]}
], "in_network" : [
{"negotiation_arrangement":"ffs","name":"Peritoneal Dialysis - Peritoneal/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0831","description":"Peritoneal Dialysis - Peritoneal/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":863.43,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Miscellaneous Dialysis - Ultrafiltration","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0881","description":"Miscellaneous Dialysis - Ultrafiltration","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":863.43,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Miscellaneous Dialysis - Ultrafiltration","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0881","description":"Miscellaneous Dialysis - Ultrafiltration","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":863.43,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Cont Cycling Peritoneal Dialysis - CCPD/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0851","description":"Cont Cycling Peritoneal Dialysis - CCPD/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":891.62,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Cont Ambulatory Peritoneal Dialysis-CAPD/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0841","description":"Cont Ambulatory Peritoneal Dialysis-CAPD/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":891.62,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Cont Cycling Peritoneal Dialysis - CCPD/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0851","description":"Cont Cycling Peritoneal Dialysis - CCPD/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":369.96,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Peritoneal Dialysis - Peritoneal/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0831","description":"Peritoneal Dialysis - Peritoneal/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":863.43,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Cont Cycling Peritoneal Dialysis - CCPD/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0851","description":"Cont Cycling Peritoneal Dialysis - CCPD/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":369.96,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Cont Ambulatory Peritoneal Dialysis-CAPD/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0841","description":"Cont Ambulatory Peritoneal Dialysis-CAPD/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":369.96,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Cont Ambulatory Peritoneal Dialysis-CAPD/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0841","description":"Cont Ambulatory Peritoneal Dialysis-CAPD/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":891.62,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Cont Ambulatory Peritoneal Dialysis-CAPD/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0841","description":"Cont Ambulatory Peritoneal Dialysis-CAPD/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":369.96,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Hemodialysis - Hemodialysis/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0821","description":"Hemodialysis - Hemodialysis/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":863.43,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Hemodialysis - Hemodialysis/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0821","description":"Hemodialysis - Hemodialysis/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":891.62,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Hemodialysis - Hemodialysis/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0821","description":"Hemodialysis - Hemodialysis/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":863.43,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Hemodialysis - Hemodialysis/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0821","description":"Hemodialysis - Hemodialysis/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":891.62,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Cont Cycling Peritoneal Dialysis - CCPD/Composite or Other Rate","billing_code_type":"RC","billing_code_type_version":"2025","billing_code":"0851","description":"Cont Cycling Peritoneal Dialysis - CCPD/Composite or Other Rate","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"per diem","negotiated_rate":891.62,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary’s home that has been made provider","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0248","description":"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary’s home that has been made provider","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86409","description":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":93.64,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0202U","description":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosag","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91315","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosag","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0172A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0225U","description":"Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86413","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosa","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91313","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosa","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0238","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0238","description":"HCPCS-Q0238","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":6.69,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0237","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0237","description":"HCPCS-Q0237","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":5.9,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"CPT-87812","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"87812","description":"CPT-87812","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":87.74,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease [COVID-19]) vaccine, single dose","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"90480","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease [COVID-19]) vaccine, single dose","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":26.9,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86769","description":"Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.58,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0235","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0235","description":"HCPCS-Q0235","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90481","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90481","description":"CPT-90481","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 25 mcg/0.25 mL dosage, for intramuscular use","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91321","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 25 mcg/0.25 mL dosage, for intramuscular use","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":173.12,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91320","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":198.31,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require suppleme","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"Q0249","description":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require suppleme","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":9.05,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"distant site telehealth services","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"G2025","description":"distant site telehealth services","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":108.71,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disea","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87811","description":"Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disea","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":48.79,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Antibody testing for a public health related pathogen, including coronavirus.","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D0605","description":"Antibody testing for a public health related pathogen, including coronavirus.","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":57.84,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 1","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1701","description":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 1","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 50mcg/0.25mL IM DOSE BOOSTER","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1711","description":"SARSCOV2 COVID-19 VAC mRNA 50mcg/0.25mL IM DOSE BOOSTER","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90613","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90613","description":"CPT-90613","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0233","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0233","description":"HCPCS-M0233","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"K1034","description":"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus type","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87636","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus type","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 50 mcg/0.5 mL dosage, for intramuscular use","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91322","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 50 mcg/0.5 mL dosage, for intramuscular use","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":190.44,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Molecular testing for a public health related pathogen, including coronavirus","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D0606","description":"Molecular testing for a public health related pathogen, including coronavirus","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":115.28,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 3","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1710","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 3","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0408U","description":"Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":16.53,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Publ","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"99072","description":"Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Publ","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86328","description":"Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":53.51,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 2","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1704","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 2","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0151A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0237","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0237","description":"HCPCS-M0237","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 3 mcg/0.23 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91318","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 3 mcg/0.23 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":77.12,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0121A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"U0002","description":"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0238","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0238","description":"HCPCS-M0238","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunoch","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87428","description":"Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunoch","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":82.63,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0223U","description":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"CPT-91323","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"91323","description":"CPT-91323","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":238.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"U0001","description":"Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0226U","description":"Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.97,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preserva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91304","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preserva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":226.24,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91317","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniq","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87635","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniq","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86408","description":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.58,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90612","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90612","description":"CPT-90612","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; ; respirator","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87633","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; ; respirator","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87426","description":"severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":41.71,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0250","description":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":529.99,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Injection, remdesivir, 1 mg","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"J0248","description":"Injection, remdesivir, 1 mg","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":8.26,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0234","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0234","description":"HCPCS-M0234","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87637","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosa","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91316","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosa","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 1","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1703","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 1","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0224U","description":"Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0141A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 10 mcg/0.23 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91319","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 10 mcg/0.23 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":111.74,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syn","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87631","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syn","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0142A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0236","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0236","description":"HCPCS-M0236","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patients home; reported only once per individual home per date of service when such v","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0201","description":"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patients home; reported only once per individual home per date of service when such v","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":45.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0249","description":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":529.99,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0171A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identi","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87913","description":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":303.36,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; respiratory","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87632","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; respiratory","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":256.93,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 3","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1708","description":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 3","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0235","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0235","description":"HCPCS-M0235","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dos","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91314","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dos","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunoassay for infectious agent antibody(ies), qualitative or semi quantitative, single-step method (eg, reagent strip);","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86318","description":"Immunoassay for infectious agent antibody(ies), qualitative or semi quantitative, single-step method (eg, reagent strip);","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":21.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"99401","description":"Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":44.77,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosag","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91312","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosag","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"J0879","description":"Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":0.28,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"outpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0235","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0235","description":"HCPCS-Q0235","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"distant site telehealth services","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"G2025","description":"distant site telehealth services","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":108.71,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dos","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91314","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 25 mcg/0.25 mL dos","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87426","description":"severe acute respiratory syndrome coronavirus (eg, SARS-CoV, SARS-CoV-2 [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":41.71,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"CPT-91323","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"91323","description":"CPT-91323","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":238.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0235","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0235","description":"HCPCS-M0235","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0238","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0238","description":"HCPCS-Q0238","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":6.69,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"99401","description":"Preventive medicine counseling and/or risk factor reduction intervention(s) provided to an individual (separate procedure); approximately 15 minutes","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":44.77,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0121A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"CPT-87812","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"87812","description":"CPT-87812","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":87.74,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90481","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90481","description":"CPT-90481","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"U0001","description":"Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0141A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 3 mcg/0.23 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91318","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 3 mcg/0.23 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":77.12,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunoch","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87428","description":"Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunoch","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":82.63,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunoassay for infectious agent antibody(ies), qualitative or semi quantitative, single-step method (eg, reagent strip);","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86318","description":"Immunoassay for infectious agent antibody(ies), qualitative or semi quantitative, single-step method (eg, reagent strip);","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":21.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90612","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90612","description":"CPT-90612","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"CPT-90613","billing_code_type":"CPT","billing_code_type_version":"2026","billing_code":"90613","description":"CPT-90613","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease [COVID-19]) vaccine, single dose","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"90480","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) (coronavirus disease [COVID-19]) vaccine, single dose","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":26.9,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Publ","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"99072","description":"Additional supplies, materials, and clinical staff time over and above those usually included in an office visit or other non-facility service(s), when performed during a Publ","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0225U","description":"Infectious disease (bacterial or viral respiratory tract infection) pathogen-specific DNA and RNA, 21 targets, including severe acute respiratory syndrome coronavirus 2 (SARS-","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0202U","description":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syn","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87631","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syn","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosa","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91316","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, bivalent, preservative free, 10 mcg/0.2 mL dosa","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0249","description":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":529.99,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniq","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87635","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe techniq","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86408","description":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); screen","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.58,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identi","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87913","description":"Infectious agent genotype analysis by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), mutation identi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":303.36,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Molecular testing for a public health related pathogen, including coronavirus","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D0606","description":"Molecular testing for a public health related pathogen, including coronavirus","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":115.28,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0224U","description":"Antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), includes titer(s), when performed","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Antibody testing for a public health related pathogen, including coronavirus.","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D0605","description":"Antibody testing for a public health related pathogen, including coronavirus.","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":57.84,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosag","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91312","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 30 mcg/0.3 mL dosag","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preserva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91304","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preserva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":226.24,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0250","description":"Intravenous infusion, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and requi","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":529.99,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86328","description":"Immunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method (eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":53.51,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Injection, remdesivir, 1 mg","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"J0248","description":"Injection, remdesivir, 1 mg","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":8.26,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosag","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91315","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, bivalent spike protein, preservative free, 10 mcg/0.2 mL dosag","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 25 mcg/0.25 mL dosage, for intramuscular use","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91321","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 25 mcg/0.25 mL dosage, for intramuscular use","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":173.12,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0408U","description":"Infectious agent antigen detection by bulk acoustic wave biosensor immunoassay, severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":16.53,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 1","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1703","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 1","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 50 mcg/0.5 mL dosage, for intramuscular use","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91322","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, 50 mcg/0.5 mL dosage, for intramuscular use","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":190.44,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0223U","description":"Infectious disease (bacterial or viral respiratory tract infection), pathogen-specific nucleic acid (DNA or RNA), 22 targets including severe acute respiratory syndrome corona","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87637","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), influenza virus types A","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 50mcg/0.25mL IM DOSE BOOSTER","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1711","description":"SARSCOV2 COVID-19 VAC mRNA 50mcg/0.25mL IM DOSE BOOSTER","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"K1034","description":"Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0226U","description":"Surrogate viral neutralization test (sVNT), severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), ELISA, plasma, serum","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.97,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"J0879","description":"Injection, difelikefalin, 0.1 microgram, (for esrd on dialysis)","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":0.28,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0236","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0236","description":"HCPCS-M0236","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-Q0237","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"Q0237","description":"HCPCS-Q0237","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":5.9,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86769","description":"Antibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19])","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":49.58,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"U0002","description":"2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disea","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87811","description":"Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disea","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":48.79,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0237","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0237","description":"HCPCS-M0237","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0172A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91320","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":198.31,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; respiratory","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87632","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; respiratory","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":256.93,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86413","description":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) antibody, quantitative","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":60.59,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"86409","description":"Neutralizing antibody, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]); titer","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":93.64,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 3","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1710","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 3","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0233","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0233","description":"HCPCS-M0233","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosa","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91313","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, spike protein, bivalent, preservative free, 50 mcg/0.5 mL dosa","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patients home; reported only once per individual home per date of service when such v","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0201","description":"Administration of pneumococcal, influenza, hepatitis b, and/or covid-19 vaccine inside a patients home; reported only once per individual home per date of service when such v","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":45.25,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; ; respirator","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87633","description":"Infectious agent detection by nucleic acid (DNA or RNA); respiratory virus (e.g., adenovirus, influenza virus, coronavirus, metapneumovirus, parainfluenza virus,; ; respirator","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":491.04,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0234","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0234","description":"HCPCS-M0234","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 10 mcg/0.23 mL dosage, tris-sucrose formulation,","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91319","description":"Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) (coronavirus disease [COVID-19]) vaccine, mRNALNP, spike protein, 10 mcg/0.23 mL dosage, tris-sucrose formulation,","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":111.74,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"91317","description":"Severe acute respiratory syndrome coronavirus 2 (SARS CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA LNP, bivalent spike protein, preservative free, 3 mcg/0.2 mL dosage","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0142A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spik","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 1","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1701","description":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 1","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require suppleme","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"Q0249","description":"Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require suppleme","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":9.05,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 3","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1708","description":"SARSCOV2 COVID-19 VAC mRNA 30mcg/0.3mL IM DOSE 3","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus type","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"87636","description":"Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]) and influenza virus type","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":168.01,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0171A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 2","billing_code_type":"CDT","billing_code_type_version":"2025","billing_code":"D1704","description":"SARSCOV2 COVID-19 VAC mRNA 100mcg/0.5mL IM DOSE 2","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":58.83,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"HCPCS-M0238","billing_code_type":"HCPCS","billing_code_type_version":"2026","billing_code":"M0238","description":"HCPCS-M0238","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","billing_code_type":"CPT","billing_code_type_version":"2025","billing_code":"0151A","description":"Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, biva","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]},
{"negotiation_arrangement":"ffs","name":"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary’s home that has been made provider","billing_code_type":"HCPCS","billing_code_type_version":"2025","billing_code":"M0248","description":"Intravenous infusion, sotrovimab, includes infusion and post administration monitoring in the home or residence; this includes a beneficiary’s home that has been made provider","negotiated_rates":[{"negotiated_prices":[{"negotiated_type":"fee schedule","negotiated_rate":69999.3,"expiration_date":"9999-12-31","billing_class":"institutional","setting":"inpatient"}],"provider_references":[635825491]}]}]}